Miguel Á. Conde

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Can we predict success from log data in VLEs? Classification of interactions for learning analytics and their relation with performance in VLE-supported F2F and online learning

Ángel F. Agudo-Peregrina, Santiago Iglesías-Pradas, Miguel Á. Conde et al. · Computers in Human Behavior · 2013 · 426 citations

Education, Computer Science, Data Science +16

Using Learning Analytics to improve teamwork assessment

Ángel Fidalgo-Blanco, María Luisa Séin-Echaluce, Francisco José García‐Peñalvo et al. · Computers in Human Behavior · 2015 · 195 citations

Management, Educational Assessment, Organizational Behavior +12

Opening Learning Management Systems to Personal Learning Environments

Francisco José García‐Peñalvo, Marc Alier, María José Casany et al. · UPCommons institutional repository (Universitat Politècnica de Catalunya) · 2020 · 135 citations · Full text

Education, Educational Technology, Information Systems +13